9.94  -0.085 (-0.85%)		04-24 16:00
Open: 10.03 High: 10.0581 Volume: 189,269		Pre. Close: 10.0254 Low: 9.885 Market Cap: 103(M)

Short term
Mid term
Targets	6-month :	12.71	1-year :	13.66
Resists	First :	10.88	Second :	11.69
Pivot price	10.36
Supports	First :	9.57	Second :	7.96
MAs	MA(5) :	9.86	MA(20) :	10.57
	MA(100) :	11.16	MA(250) :	11.23
MACD	MACD :	-0.5	Signal :	-0.4
%K %D	K(14,3) :	23.4	D(3) :	16.7
RSI	RSI(14): 33.3
52-week	High :	13.32	Low :	8.63

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ GNOM ] has closed above bottom band by 28.4%. Bollinger Bands are 73.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	10.07 - 10.13	10.13 - 10.18
Low:	9.75 - 9.81	9.81 - 9.87
Close:	9.85 - 9.95	9.95 - 10.04

The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.

Fri, 19 Apr 2024
9 Best Biotech ETFs for 2024 - AOL

Thu, 11 Apr 2024
Investing in Pharma: How to Spot Leading Drug Candidates - Global X

Mon, 11 Mar 2024
5 Small Biotech ETFs to Watch (Updated 2024) - Investing News Network

Fri, 01 Mar 2024
Genomic and global gene expression profiling in pediatric and young adult acute leukemia with PICALM::MLLT10 ... - Nature.com

Thu, 29 Feb 2024
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - U.S News & World Report Money

Mon, 08 Jan 2024
3 Biotech ETFs to Bet on Now - Nasdaq

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Financial Services
Industry: Asset Management - Global
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.